Tesamorelin

What it is: A stabilized GHRH analog originally developed to treat HIV-related lipodystrophy. Stronger and longer-acting than Sermorelin.

What it does: Expect targeted reduction of visceral (belly) fat — Tesamorelin is uniquely good at this — plus improved cognition, better lipid profile, and modest lean tissue gains.

How it's used: Daily subcutaneous injection at 1-2 mg.